BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 28377234)

  • 1. Potential biomarkers for effective screening of neonatal sepsis infections: An overview.
    Chauhan N; Tiwari S; Jain U
    Microb Pathog; 2017 Jun; 107():234-242. PubMed ID: 28377234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic biomarkers for diagnostic of early-onset neonatal sepsis.
    Memar MY; Alizadeh N; Varshochi M; Kafil HS
    J Matern Fetal Neonatal Med; 2019 Jan; 32(1):143-153. PubMed ID: 28797204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procalcitonin versus C-reactive protein: review of kinetics and performance for diagnosis of neonatal sepsis.
    Eschborn S; Weitkamp JH
    J Perinatol; 2019 Jul; 39(7):893-903. PubMed ID: 30926891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-alpha in the diagnosis of neonatal sepsis.
    Kocabaş E; Sarikçioğlu A; Aksaray N; Seydaoğlu G; Seyhun Y; Yaman A
    Turk J Pediatr; 2007; 49(1):7-20. PubMed ID: 17479639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Assessment of Cytokine Pattern in Early and Late Onset of Neonatal Sepsis.
    Khaertynov KS; Boichuk SV; Khaiboullina SF; Anokhin VA; Andreeva AA; Lombardi VC; Satrutdinov MA; Agafonova EA; Rizvanov AA
    J Immunol Res; 2017; 2017():8601063. PubMed ID: 28367457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplex Cytokine Profiling Identifies Interleukin-27 as a Novel Biomarker For Neonatal Early Onset Sepsis.
    He Y; Du WX; Jiang HY; Ai Q; Feng J; Liu Z; Yu JL
    Shock; 2017 Feb; 47(2):140-147. PubMed ID: 27648693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early and late markers for the detection of early-onset neonatal sepsis.
    Bender L; Thaarup J; Varming K; Krarup H; Ellermann-Eriksen S; Ebbesen F
    Dan Med Bull; 2008 Nov; 55(4):219-23. PubMed ID: 19232162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum amyloid A - A prime candidate for identification of neonatal sepsis.
    Bengnér J; Quttineh M; Gäddlin PO; Salomonsson K; Faresjö M
    Clin Immunol; 2021 Aug; 229():108787. PubMed ID: 34175457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of serum amyloid A concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal sepsis in premature infants.
    Cetinkaya M; Ozkan H; Köksal N; Celebi S; Hacimustafaoğlu M
    J Perinatol; 2009 Mar; 29(3):225-31. PubMed ID: 19078972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical criteria for pathogen bacteria in term newborn suspected of neonatal sepsis].
    Glusko-Charlet A; Fontaine C; Raucy M; Barcat L; Lahana A; Erbani R; Poirie G; Kongolo G; Diouf M; Leke A; Gondry J; Tourneux P
    Arch Pediatr; 2017 Oct; 24(10):934-941. PubMed ID: 28893488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel method to detect bacterial infection in premature infants: Using a combination of inflammatory markers in blood and saliva.
    Chen IL; Huang HC; Ou-Yang MC; Chen FS; Chung MY; Chen CC
    J Microbiol Immunol Infect; 2020 Dec; 53(6):892-899. PubMed ID: 31883971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of progranulin as a novel diagnostic biomarker for early-onset sepsis in neonates.
    Yang KD; He Y; Xiao S; Ai Q; Yu JL
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2405-2414. PubMed ID: 32720089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Umbilical cord blood procalcitonin and C reactive protein concentrations as markers for early diagnosis of very early onset neonatal infection.
    Joram N; Boscher C; Denizot S; Loubersac V; Winer N; Roze JC; Gras-Le Guen C
    Arch Dis Child Fetal Neonatal Ed; 2006 Jan; 91(1):F65-6. PubMed ID: 16371391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognising early onset neonatal sepsis: an essential step in appropriate antimicrobial use.
    van Herk W; Stocker M; van Rossum AM
    J Infect; 2016 Jul; 72 Suppl():S77-82. PubMed ID: 27222092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of serum procalcitonin concentrations for the diagnosis of sepsis in neonates.
    Ali AM; Moaz MA; Ghoniem E; Abd El Motaleb T; Sheri N
    Egypt J Immunol; 2008; 15(1):75-84. PubMed ID: 20306671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Concentrations of Interleukin-6, Procalcitonin, and C-Reactive Protein: Discrimination of Septical Complications and Systemic Inflammatory Response Syndrome after Pediatric Surgery.
    Neunhoeffer F; Plinke S; Renk H; Hofbeck M; Fuchs J; Kumpf M; Zundel S; Seitz G
    Eur J Pediatr Surg; 2016 Apr; 26(2):180-5. PubMed ID: 25643248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in developing biosensing based platforms for neonatal sepsis.
    Balayan S; Chauhan N; Chandra R; Kuchhal NK; Jain U
    Biosens Bioelectron; 2020 Dec; 169():112552. PubMed ID: 32931992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin and Neonatal Sepsis: Is This the Biomarker We Are Looking For?
    Bell SG
    Neonatal Netw; 2017 Nov; 36(6):380-384. PubMed ID: 29185950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of cytokines to predict neonatal sepsis.
    Ye Q; Du LZ; Shao WX; Shang SQ
    Pediatr Res; 2017 Apr; 81(4):616-621. PubMed ID: 27997530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular imprinting based electrochemical biosensor for identification of serum amyloid A (SAA), a neonatal sepsis biomarker.
    Balayan S; Chauhan N; Chandra R; Jain U
    Int J Biol Macromol; 2022 Jan; 195():589-597. PubMed ID: 34920065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.